2012 CONSULTATION RESPONSES

The Royal Pharmaceutical Society responded to the following consultations in 2012.

January 2012

Implementing a Duty of Candour - a new contractual requirement on providers | Department of Health

Draft regulations under the Health Act 2009: Market entry by means of pharmaceutical needs assessments and quality and performance | PNA

Service standards on confidentiality | Faculty of Sexual and Reproduction Healthcare

Cost effectiveness and efficiency in health professional regulation | CHRE

Medicines Act consultation | MHRA

NICE's proposals for changes to the process and methods for public health guidance development | NICE

February 2012

Transposition of Pharmacovigilance Consultation MLX 374 | MHRA

Consultation on potential COF indicators | NICE

Good Medical Practice | GMC

80 Clarityn Allergy 10mg Tablets (Loratidine) 30 Tablet Pack SizeRequest to reclassify a product from P to GSL | MHRA

Potential new indicators for the 2013/14 Quality and Outcomes Framework (QOF) | NICE

March 2012

Call for Evidence on induction for doctors new to practising in the UK | GMC

Draft 2012 fees rules for the General Pharmaceutical Council | General Pharmaceutical Council

Neutropenic Sepsis | NICE

ARM 81 Imodium Instants (loperamide hydrochloride) 12 tablet pack size | MHRA

April 2012

Pharmaceutical Services Regulations | Welsh Government

May 2012

Making Things Better – Improving the ways we deal with complaints and concerns about social services in Wales | Welsh Government

Social Services (Wales) Bill Consultation | Welsh Government

Modernising pharmacy regulation: A consultation on the draft standards for registered pharmacies | General Pharmaceutical Council

June 2012

Healthy Lives, Healthy People: Towards a workforce strategy for the public health system | Department of Health

Dyspepsia/GORD | NICE

Regulation of Health Professionals | Law Commission

July 2012

GPHC draft Amendment to Rules consultation 2012 | General Pharmaceutical Council

Fair Playing Field – for the benefit of patients | Monitor

Carbon Footprinting Pharmaceuticals and Medical Devices | NHS Sustainable Development Unit

Review of NHS Pharmaceutical Care of patients in the community in Scotland | Scottish Government

August 2012

How to change the legal classification of a medicine in the UK | MHRA

Liberating the NHS: No decision about me, without me. Further consultation on proposals to shared decision-making | Department of Health

Clarityn Allergy 1mg/ml Syrup (Loratidine) 70ml Pack Size | MHRA

September 2012

Quality in the new health system: Maintaining and improving quality from April 2013 | Department of Health

Developing our NHS care objectives: A consultation on the draft mandate to the NHS Commissioning Board | Department of Health

Joint Strategic Needs Assessments and Joint Health and Wellbeing Strategies | Department of Health

Information: to share or not to share? Information Governance Review | Department of Health

Integration of health and social care | Scottish Government

October 2012

Enabling integrated care in Wales | NHS Wales Informatics Service

Proposals for commissioners to deliver best value | Department of Health

Protecting and promoting patients’ interests – licensing providers of NHS services | Department of Health

The development and updating of local formularies | NICE

Better care for patients: defining the role of general practice in 2022 – a call for action | Royal College of GPs

Early access to medicines scheme in the UK | MHRA

Access to medical technologies in Wales | National Assembly for Wales

November 2012

UKMi and Medicines Optimisation in England | UKMi

The next phase: Our consultation on our strategy for 2012 to 2016  | CQC

Performance review of health and care professional regulators | CHRE

Together for health - delivering end of life care | Welsh Government

Falsified medicines directive (FMD) | MHRA

Draft regulations under the National Health Service (Wales) Act 2006 - The National Health Service (Pharmaceutical Services) (Wales) Regulations | NHS Wales

Controlled drugs (supervision of management and use) regulations 2013 | Department of Health

Implementation of NSF for diabetes in Wales | National Assembly for Wales

Review of the Shortage Occupation Lists for the UK and Scotland and Creative Occupations | Migration Advisory Committee

Draft regulations under the National Health Service (Wales) Act 2006 - The National Health Service (Pharmaceutical Services) (Wales) Regulations | Welsh Government

Safeguarding Choice A draft Assisted Dying Bill for consultation | All Party Parliamentary Group

Proposed regulations to implement Council Directive 2010/32/EU on preventing sharps injuries in the hospital and healthcare sector. | Health and Safety Executive

December 2012

Draft quality indicators for palliative and end of life care | Healthcare Improvement Scotland